HomeAI · summaries
Storia in 2 fonti
Amylyx Pharmaceuticals Inc (AMLX) Gets a Buy from LifeSci Capital
LifeSci Capital analyst Rami Katkhuda maintained a Buy rating on Amylyx Pharmaceuticals Inc today and set a price target of $44.00.Summer Sale -...
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
morningstar.com
Amylyx Pharmaceuticals Announces Pricing of an Upsized $500 Million Underwritten Public Offering of Common Stock
Amylyx Pharmaceuticals Announces Pricing of an Upsized $500 Million Underwritten Public Offering of Common Stock
- ·
markets.businessinsider.com
Amylyx Pharmaceuticals Inc (AMLX) Gets a Buy from LifeSci Capital
LifeSci Capital analyst Rami Katkhuda maintained a Buy rating on Amylyx Pharmaceuticals Inc today and set a price target of $44.00.Summer Sale -...